New consortium consisting Competence Centre on Health Technologies (EE), University of Tartu Estonian Genome Center (EE), Tallinn University of Technology eMedicine Laboratory (EE), BioEximi OÜ (EE), Duodecim Medical Publications Ltd. (FI), Medisapiens Ltd. (FI) and CBRA Genomics (PT) intend to study the terms for the development of clinically valid and commercially viable personalised medicine products and services. The result will describe products and services which the consortium expects to bring to the market together.
The project is co-financed by the European Regional Development Fund via Enterprise Estonia, the CCHT and its consortium partners.
“Duodecim is excited to study the possibilities to use our clinical decision support system in the integration of genetic data and clinical outcomes”, explains Dr Pekka Mustonen, CEO of Duodecim Medical Publications Ltd.
For more information: